<DOC>
	<DOCNO>NCT01304225</DOCNO>
	<brief_summary>This study investigate clinical efficacy safety PASCAL laser ( PAttern SCAn Laser ) diabetic retinopathy . Patients proliferative severe nonproliferative retinopathy treat panretinal photocoagulation utilize different treatment strategy . The investigator believe use `` low '' laser parameter , clinical response may equivalent less adverse effect .</brief_summary>
	<brief_title>Panretinal Photocoagulation Diabetic Retinopathy With PASCAL Laser</brief_title>
	<detailed_description />
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<criteria>proliferative severe nonproliferative diabetic retinopathy ( type 1 type 2 ) best correct visual acuity 20/50 good capability read follow instruction capability sign consignment term best correct visual acuity bad 20/50 significant macular edema responsible visual acuity lower 20/50 medium opacity ( include vitreous hemorrhage visual axis , reabsorb inferior vitreous hemorrhage ) previous laser treatment ( PRP , focal macular grid ) glaucoma ( confirm suspicious ) diseases retina optic nerve previous ocular surgery last 6 month impossibility obtain good quality image retinography , angiography OCT</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>diabetic retinopathy</keyword>
	<keyword>photocoagulation</keyword>
	<keyword>PASCAL laser</keyword>
</DOC>